The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for GG Chiang


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED binding.EBI
Abbvie
Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2.EBI
Abbvie
Discovery and development of potent and selective inhibitors of histone methyltransferase g9a.EBI
Abbvie
The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia.EBI
Abbvie
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.EBI
AbbVie
Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.EBI
Inception Therapeutics
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.EBI
Effector Therapeutics
SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT).EBI
Abbvie
Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitorsBDB
Novartis
Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitorsBDB
Merck Sharp & Dohme
Compounds and compositions as protein kinase inhibitorsBDB
TBA